display Latest news from University of Texas MD Anderson Cancer Center on News en-us Copyright 2025 News 115 31 / /images/newswise-logo-rss.gif /articles/md-anderson-breaks-ground-on-new-sugar-land-location/?sc=rsin /articles/md-anderson-breaks-ground-on-new-sugar-land-location/?sc=rsin Mon, 31 Mar 2025 19:10:40 EST The University of Texas MD Anderson Cancer Center today broke ground on a new 470,000-square-foot facility in Sugar Land, bringing a range of cancer services and MD Anderson's unparalleled patient experience closer to those living in Southwest Houston and the surrounding areas. University of Texas MD Anderson Cancer Center /articles/surgery-may-not-be-necessary-to-treat-invasive-breast-cancer/?sc=rsin /articles/surgery-may-not-be-necessary-to-treat-invasive-breast-cancer/?sc=rsin Fri, 28 Mar 2025 08:00:00 EST Surgery may not be the best next course of treatment for patients with early-stage breast cancer who had a complete response to neoadjuvant (pre-surgical) chemotherapy and standard radiation treatment, according to new data from researchers at The University of Texas MD Anderson Cancer Center. University of Texas MD Anderson Cancer Center /articles/md-anderson-research-highlights-for-march-27-2025/?sc=rsin /articles/md-anderson-research-highlights-for-march-27-2025/?sc=rsin Thu, 27 Mar 2025 18:10:09 EST The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. University of Texas MD Anderson Cancer Center /articles/two-md-anderson-researchers-elected-aaas-fellows/?sc=rsin /articles/two-md-anderson-researchers-elected-aaas-fellows/?sc=rsin Thu, 27 Mar 2025 05:20:43 EST In recognition of their significant achievements to advance cancer care and research, Lauren Byers, M.D., and Paul Scheet, Ph.D., from The University of Texas MD Anderson Cancer Center have been elected fellows of the American Association for the Advancement of Science (AAAS). University of Texas MD Anderson Cancer Center /articles/md-anderson-names-jeffrey-e-lee-m-d-chief-medical-executive/?sc=rsin /articles/md-anderson-names-jeffrey-e-lee-m-d-chief-medical-executive/?sc=rsin Wed, 26 Mar 2025 21:05:47 EST The University of Texas MD Anderson Cancer Center today announced that Jeffrey E. Lee, M.D., an internationally regarded leader in the field of oncology, has been appointed chief medical executive (CME) effective April 1. University of Texas MD Anderson Cancer Center /articles/md-anderson-research-highlights-for-march-12-2025/?sc=rsin /articles/md-anderson-research-highlights-for-march-12-2025/?sc=rsin Wed, 12 Mar 2025 12:00:22 EST The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. University of Texas MD Anderson Cancer Center /articles/f-w-bert-and-mae-dean-wheeler-foundation-establishes-nurse-leadership-academy-at-md-anderson-with-9-million-gift/?sc=rsin /articles/f-w-bert-and-mae-dean-wheeler-foundation-establishes-nurse-leadership-academy-at-md-anderson-with-9-million-gift/?sc=rsin Wed, 05 Mar 2025 08:25:37 EST The University of Texas MD Anderson Cancer Center today announced a $9 million gift from the F. W. Bert and Mae Dean Wheeler Foundation to establish the F. W. Bert and Mae Dean Wheeler Nurse Leadership Academy. University of Texas MD Anderson Cancer Center /articles/md-anderson-research-highlights-for-february-26-2025/?sc=rsin /articles/md-anderson-research-highlights-for-february-26-2025/?sc=rsin Wed, 26 Feb 2025 16:45:20 EST The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. University of Texas MD Anderson Cancer Center /articles/md-anderson-researchers-develop-novel-antibody-toxin-conjugate/?sc=rsin /articles/md-anderson-researchers-develop-novel-antibody-toxin-conjugate/?sc=rsin Tue, 25 Feb 2025 05:00:00 EST Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors. According to preclinical results published today in Nature Cancer, the new approach combined the benefits of more well-known antibody-drug conjugates (ADCs) with those of immunotherapies. University of Texas MD Anderson Cancer Center /articles/ut-md-anderson-and-texas-children-s-hospital-announce-joint-venture-to-end-childhood-cancer/?sc=rsin /articles/ut-md-anderson-and-texas-children-s-hospital-announce-joint-venture-to-end-childhood-cancer/?sc=rsin Wed, 19 Feb 2025 21:10:10 EST The University of Texas MD Anderson Cancer Center and Texas Children's Hospital have announced a transformational collaboration dedicated solely to pediatric cancer care. The collaboration has a single mission: to end childhood cancer. University of Texas MD Anderson Cancer Center /articles/md-anderson-receives-nearly-23-million-in-cprit-funding-for-cancer-research-faculty-recruitment/?sc=rsin /articles/md-anderson-receives-nearly-23-million-in-cprit-funding-for-cancer-research-faculty-recruitment/?sc=rsin Wed, 19 Feb 2025 21:05:03 EST The University of Texas MD Anderson Cancer Center today was awarded nearly $23 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of 20 cancer research projects to advance new breakthroughs in discovery, translational, clinical and prevention science. In addition, CPRIT awarded $2 million for the recruitment of one first-time, tenure-track faculty member. University of Texas MD Anderson Cancer Center /articles/scientists-find-new-biomarker-that-predicts-cancer-aggressiveness/?sc=rsin /articles/scientists-find-new-biomarker-that-predicts-cancer-aggressiveness/?sc=rsin Thu, 13 Feb 2025 21:30:31 EST Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD Anderson Cancer Center have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers. University of Texas MD Anderson Cancer Center /articles/md-anderson-research-highlights-for-february-10-2025/?sc=rsin /articles/md-anderson-research-highlights-for-february-10-2025/?sc=rsin Mon, 10 Feb 2025 17:00:00 EST The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This issue includes studies to be presented this week at the 2025 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium. University of Texas MD Anderson Cancer Center /articles/combination-of-dual-targeted-therapies-and-chemotherapy-shows-high-response-rates-in-braf-mutated-metastatic-colorectal-cancer/?sc=rsin /articles/combination-of-dual-targeted-therapies-and-chemotherapy-shows-high-response-rates-in-braf-mutated-metastatic-colorectal-cancer/?sc=rsin Sat, 25 Jan 2025 15:00:00 EST Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy regimen, according to results from the Phase III BREAKWATER trial led by researchers at The University of Texas MD Anderson Cancer Center. University of Texas MD Anderson Cancer Center /articles/md-anderson-research-highlights-for-january-22-2025/?sc=rsin /articles/md-anderson-research-highlights-for-january-22-2025/?sc=rsin Wed, 22 Jan 2025 12:00:38 EST HOUSTON ― The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. University of Texas MD Anderson Cancer Center /articles/exxonmobil-donates-10-million-to-fund-md-anderson-led-be-well-beaumont-initiative/?sc=rsin /articles/exxonmobil-donates-10-million-to-fund-md-anderson-led-be-well-beaumont-initiative/?sc=rsin Mon, 13 Jan 2025 18:35:45 EST In an effort to improve public health and reduce cancer risk in East Texas, leaders in Beaumont are working with The University of Texas MD Anderson Cancer Center to launch Be Well(tm) Beaumont through a newly announced $10 million gift from ExxonMobil. University of Texas MD Anderson Cancer Center /articles/chances-of-quitting-smoking-improve-with-integrated-care-including-medication-and-counseling/?sc=rsin /articles/chances-of-quitting-smoking-improve-with-integrated-care-including-medication-and-counseling/?sc=rsin Mon, 13 Jan 2025 11:00:00 EST Smokers undergoing lung cancer screening may have the best chance of quitting if they receive integrated care, which includes medication and comprehensive counseling with tobacco treatment specialists, according to researchers at The University of Texas MD Anderson Cancer Center. University of Texas MD Anderson Cancer Center /articles/md-anderson-research-highlights-for-january-9-2025/?sc=rsin /articles/md-anderson-research-highlights-for-january-9-2025/?sc=rsin Thu, 09 Jan 2025 19:40:38 EST The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. University of Texas MD Anderson Cancer Center /articles/md-anderson-and-myriad-genetics-form-strategic-alliance-to-evaluate-clinical-utility-of-myriad-s-molecular-residual-disease-assay/?sc=rsin /articles/md-anderson-and-myriad-genetics-form-strategic-alliance-to-evaluate-clinical-utility-of-myriad-s-molecular-residual-disease-assay/?sc=rsin Tue, 07 Jan 2025 08:00:09 EST MD Anderson and Myriad announced a five-year strategic collaboration to accelerate the clinical evaluation and development of Myriad's molecular residual disease assay. University of Texas MD Anderson Cancer Center /articles/patients-with-heart-disease-may-be-at-increased-risk-for-advanced-breast-cancer/?sc=rsin /articles/patients-with-heart-disease-may-be-at-increased-risk-for-advanced-breast-cancer/?sc=rsin Thu, 02 Jan 2025 11:00:00 EST Patients diagnosed with late-stage or metastatic breast cancer have a statistically significant increased risk of pre-diagnosis cardiovascular disease (CVD) compared to those with early-stage cancer at diagnosis, according to researchers from The University of Texas MD Anderson Cancer Center. University of Texas MD Anderson Cancer Center